Regulatory status Not FDA-approved for any use
Reported side effects of corticosteroids include: Hydroelectrolytic disorders: sodium retention, potassium loss, hypokalemic alkalosis, fluid retention, congestive heart failure in susceptible patients, hypertension Musculoskeletal: muscle weakness, myopathy, loss of muscle mass, aggravation of myasthenic symptoms in myasthenia gravis, osteoporosis, vertebral compression fractures, aseptic necrosis of the head of the femur and humerus, pathologic fracture of long bones, tendon rupture Dermatological: impaired wound healing, atrophy and thinning of the skin, fragile skin, petechiae and ecchymoses, facial erythema, increased sweating, suppression of reactions to skin tests, allergic dermatitis, urticaria, and angioedema
BPC-157 (Body Protection Compound, 15-residue pentadecapeptide) and TB-500 (synthetic fragment of thymosin beta-4) are extensively co-investigated in soft-tissue, angiogenesis and cell-migration research
Is downtime required
Insufficient B12 can damage the myelin sheath, leading to nerve degeneration and cognitive issues
It is available in the quantity of one (10ml Vial, 30ml Vial), three (30ml Vial), and five (30ml Vial)
